Journal
LANCET DIABETES & ENDOCRINOLOGY
Volume 6, Issue 6, Pages 500-514Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S2213-8587(17)30325-X
Keywords
-
Categories
Funding
- Biotechnologies and Clinical Medicine of the University of Rome, Sapienza
- University of Rome, Sapienza [C26V157CMC]
Ask authors/readers for more resources
Follicular thyroid cancer is the second most common differentiated thyroid cancer histological type and has been overshadowed by its more common counterpart-papillary thyroid cancer-despite its unique biological behaviour and less favourable outcomes. In this Review, we comprehensively review the literature on follicular thyroid cancer to provide an evidence-based guide to the management of these tumours, to highlight the lack of evidence behind guideline recommendations, and to identify changes and challenges over the past decades in diagnosis, prognosis, and treatment. We highlight that correct identification of cancer in indeterminate cytological samples is challenging and ultrasonographic features can be misleading. Despite certain unique aspects of follicular thyroid cancer presentation and prognosis, no specific recommendations exist for follicular thyroid cancer and Hurthle cell carcinoma in evidence-based guidelines. Efforts should be made to stimulate additional research in this field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available